Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? October 22, 2014
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics October 17, 2014
Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression October 14, 2014
A functional selectivity mechanism at the serotonin-2A GPCR involves ligand-dependent conformations of intracellular loop 2 October 8, 2014
Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor October 6, 2014
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction September 11, 2014
